PG
Procter & Gamble Co Consumer Staples Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics S&P 500Dow 30Russell 3000
$161.57Close
$647.8BMarket cap
$135.03 – $164.7252-week range
Jan 22, 2027Next report · estimated
Highlights
Strengths
- Near its high 2% below its 52-week high
- Accumulation up-day volume 1.5× down-day volume over 50 sessions
Cautions
- Not in an uptrend 5 of 8 trend conditions
- Extended 4.4 ATR above its 50-day average
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
2%
1wk
up 0.3%
price change
1mo
up 11.9%
price change
12-month return
up 10%
market up 11% ·
its own 0%
F-score
6 / 9
Mixed
Altman Z
7.97
Low risk
P/E
40.4×
price / earnings
PEG
22.76
P/E / EPS growth
P/B
11.9×
price / book
Earnings yield
up 3.0%
EBIT / enterprise value
Cheaper than
32%
of the market · expensive
Revenue growth
up 3%
year on year
EPS growth
up 1%
latest quarter · +16 pts
Sales growth
up 4%
latest quarter · +2 pts
ROE
up 30%
return on equity
Free cash margin
up 17%
$15.1B FCF
D/E
0.42
long-term debt / equity
Net debt / EBITDA
0.6×
Interest cover
—EBIT / interest
Piotroski tests
- profitability slipped from last year
- short-term liquidity weakened
- gross margin narrowed
- profitable on its assets
- generating cash from operations
- profits backed by cash
- reduced long-term debt
- no new shares issued
- assets working harder
Repair signals
- Long-term debt down 9% ($25.0B → $22.8B)
Trade setup
ATR%
1.9%
$3.09 a day · 2×ATR $155.40
RS
64 / 99
vs the universe
Trend
5 / 8
150-day under the 200-day, under 30% off the low, RS under 70
Relative volume
1.3×
vs 50-day average
Up/down volume
1.50
50 sessions
Implied move
—
no scheduled report
Trend template · 5 of 8
- Price above the 150 and 200-day averages: passes
- 150-day average above the 200-day: fails
- 200-day average rising for a month: passes
- 50-day average above the 150 and 200-day: passes
- Price above the 50-day average: passes
- At least 30% above the 52-week low: fails
- Within 25% of the 52-week high: passes
- RS rank 70 or higher: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- Interest covered
- No material dilution
- Profits tracking cash
- Margins and revenue not shrinking
Last reported
Oct 22, 2026
Results reaction
Oct 22, 2026+5% vs market2 sessions after results
Options
$7.7M19.3% IV · activity
Financials
- Gross 50%
- Net 18%
- Free cash 17%
- Cash
- Long-term debt
| FY2021Jun 30, 2021 | FY2022Jun 30, 2022 | FY2023Jun 30, 2023 | FY2024Jun 30, 2024 | FY2025Jun 30, 2025 | FY2026Jun 30, 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $76.1B | $80.2B | $82.0B | $84.0B | $84.3B | $87.0B |
| Gross margin | 51% | 47% | 48% | 51% | 51% | 50% |
| Operating income | $18.0B | $17.8B | $18.1B | $18.5B | $20.5B | $19.7B |
| Net income | $14.3B | $14.7B | $14.7B | $14.9B | $16.0B | $16.0B |
| Net margin | 19% | 18% | 18% | 18% | 19% | 18% |
| Earnings per share | $5.50 | $5.81 | $5.90 | $6.02 | $6.51 | $6.62 |
| Free cash flow | $15.6B | $13.6B | $13.8B | $16.5B | $14.0B | $15.1B |
| Free cash margin | 20% | 17% | 17% | 20% | 17% | 17% |
| Cash | $10.3B | $7.2B | $8.2B | $9.5B | $9.6B | $9.9B |
| Long-term debt | $23.1B | $22.8B | $24.4B | $25.3B | $25.0B | $22.8B |
| Shareholders' equity | $46.7B | $46.9B | $47.1B | $50.6B | $52.3B | $54.3B |
| Shares outstanding | 4.01bn | 4.01bn | 4.01bn | 4.01bn | 4.01bn | 4.01bn |
What options price now
- Expected 1-month range The at-the-money straddle for the expiry nearest a month out, as a share of the price: the move, either way, the option market is pricing by then. The range is the price plus and minus that move; the stock ends inside it a little more often than not. Methodology
- $155 – $168 ±4.2% by Nov 27, 2026
- Swings expected vs recent The daily swings the options are priced for (implied volatility) against the swings the stock actually had over the last 20 sessions (realised volatility). Bigger means options charge for more movement than the stock has been delivering; smaller, less. On a contract row, that contract's own implied volatility over the stock's realised. Methodology
- Smaller 19.3% priced · 26.2% recent
- Next month vs later At-the-money implied volatility for 8-45 day expiries over 46-90 day ones: whether options price the coming month as choppier or calmer than the two after it. Ahead of a report it usually reads choppier, and the extra comes out once the report is out. Methodology
- About the same
- Crash protection What options that pay off in a fall cost against options that pay off in a rise (the 25-delta skew), compared with this company's own normal - the median of its stored nightly readings, once there are 20 - and with five sessions ago. Protection costs a little more than upside on most shares. More than usual means readers of the chain are paying up to insure against a drop; it does not say which way the stock will go. Methodology
- past week: costs more
Positioning
- Premium traded
- $7.7M calls $5.0M · puts $2.7M · latest session
- 0.53× -0.05 over the week
- Open interest added The change over five sessions in option positions left open overnight, calls and puts. A rise means positions were added. It cannot say whether they were bought or sold, so more calls is not a vote for a rise: a call is as often sold against shares already held. Methodology
- calls +28.86k · puts -5.55k past week
For options traders: ATM IV 19.3% (+0.6% 1w) · 1m ÷ 3m IV 1.01 · 25Δ skew 1.5 pts · Net GEX $122.5M
Most traded contracts
No contract passed the liquidity filters this week.
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Oct 22, 2026 | Quarterly ↗ | Sep 30, 2026 | 22d |
| Aug 4, 2026 | Annual ↗ | Jun 30, 2026 | 35d |
| Apr 24, 2026 | Quarterly ↗ | Mar 31, 2026 | 24d |
| Jan 23, 2026 | Quarterly ↗ | Dec 31, 2025 | 23d |
| Oct 24, 2025 | Quarterly ↗ | Sep 30, 2025 | 24d |
| Aug 4, 2025 | Annual ↗ | Jun 30, 2025 | 35d |
| Apr 24, 2025 | Quarterly ↗ | Mar 31, 2025 | 24d |
| Jan 22, 2025 | Quarterly ↗ | Dec 31, 2024 | 22d |
| Oct 18, 2024 | Quarterly ↗ | Sep 30, 2024 | 18d |
| Aug 5, 2024 | Annual ↗ | Jun 30, 2024 | 36d |
| Apr 19, 2024 | Quarterly ↗ | Mar 31, 2024 | 19d |
| Jan 23, 2024 | Quarterly ↗ | Dec 31, 2023 | 23d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 30, 2026 | Other events ↗ |
| Oct 22, 2026 | Regulation FD ↗ |
| Oct 22, 2026 | Results ↗ |
| Oct 16, 2026 | Shareholder vote ↗ |
| Oct 13, 2026 | Regulation FD ↗ |
| Jul 29, 2026 | Regulation FD ↗ |
| Jul 29, 2026 | Director or officer change · Regulation FD ↗ |
| Jul 29, 2026 | Results ↗ |
| Jul 14, 2026 | Regulation FD ↗ |
| Apr 24, 2026 | Regulation FD ↗ |
| Apr 24, 2026 | Results ↗ |
| Apr 14, 2026 | Regulation FD ↗ |